openPR Logo
Press release

Intravenous Solutions Market Opportunity Analysis, 2026

08-13-2018 04:45 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is expected to grow at high rate over the forecast period, owing to increasing diseases causing fluid loss, dehydration and malnutrition, increasing rates of chronic diseases, and surgeries.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1134

Increasing prevalence of Diarrhea is expected to boost the growth of intravenous solutions market in near future

According to World Health Organization (WHO) in 2017, diarrhea is the second largest cause of death around the globe. Around 1.7 billion people suffers for diarrhea every year and causes around 525,000 deaths. IV solutions are given to the patients suffering to maintain their body fluid level as diarrhea causes dehydration, malnutrition, and excess fluid loss from the body. Thus, increasing prevalence of diarrhea is expected to rise demand for IV solutions and fuel its market growth in near future. According to WHO in 2017, around 180,000 people suffer from burns yearly and between 20 and 50 million people suffers from severe injuries and blood loss due to road accidents.

Burns, shocks and blood loss due to trauma or road accidents causes severe fluid loss from body, which can be retained by giving IV solution to patients. Increasing incidents of burns, shocks and excess fluid loss due to trauma and accidents are expected to boost the growth of IV solutions market in near future. Rising prevalence of chronic diseases and surgeries are also expected to fuel IV solution market as IV fluids are given to the patients suffering from chronic diseases for recovery after the surgery. However, the presence of domestic players which provide low quality products that does not provide optimum results are hampering the market growth.

Asia Pacific is expected to dominate IV solution market due to high ratio of diseases related to fluid loss

Regional market for the intravenous solutions market by Coherent Market Insights is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Asia Pacific expected to hold the dominant position in market due to highest rate of diarrhea, chronic diseases, and increasing rate of surgeries. According to the United Nations International Children's Emergency Fund (UNICEF) in 2016, every two children out of four in Asia is suffering from diarrhea and malnutrition. Rate of diarrhea is very high in Bangladesh, China, and Pakistan.

The rate of chronic diseases in Asia is high with increasing population in China in India. Africa is expected to be the second largest contributor to the IV solution market, owing to high ratio of diseases such as metabolic acidosis, hyponatremia, and fistula drainage due to poor sanitation and improper healthcare system. Prevalence of road accidents and trauma is very high in Africa that resulting excess loss of body fluid, which can be retained with IV solutions. According to WHO in 2015, Africa had highest prevalence of road accidents among all others regions.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1134

Key players are collaborating with different organizations to increase the market penetration of products

Major players in global intravenous solutions market are B. Braun Melsungen AG, Baxter, Fresenius Kabi AG, Grifols, ICU Medical, Inc., Omnicare, JW Life Science, Hospira Inc, Sichuan Kelun Pharmaceutical, and Vifor Pharma. Key players are collaborating with different organizations and working with them to reduce malnutrition by supplying their product. In 2017, Baxter collaborated with American Society for Parenteral and Enteral Nutrition (ASPEN) an organization, which drives the science and practice of clinical nutrition to reduce the incidents of malnutrition in America.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Solutions Market Opportunity Analysis, 2026 here

News-ID: 1177431 • Views:

More Releases from Coherent Market Insights

Pediatric Interventional Cardiology Market Regional Growth and Insights: Key Drivers and Trends through 2031 | Siemens Healthineers, NuMed Inc., Medtronic
Pediatric Interventional Cardiology Market Regional Growth and Insights: Key Dri …
The pediatric interventional cardiology market is estimated to be valued at USD 2.88 Bn in 2024 and is expected to reach USD 5.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031. The research report on the Pediatric Interventional Cardiology Market provides an in-depth analysis of the industry's current state and projected growth from 2024 to 2031. It presents key statistics, trends, and market
Dry Eye Disease Market Forecast: Size, Share, Growth, Key Drivers and Regional Trends for 2024 to 2031 | Novartis AG, Alcon Inc., I-MED Pharma Inc
Dry Eye Disease Market Forecast: Size, Share, Growth, Key Drivers and Regional T …
The dry eye disease market is estimated to be valued at USD 7.33 Bn in 2024 and is expected to reach USD 13.26 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031. The research report on the Dry Eye Disease Market provides an in-depth analysis of the industry's current state and projected growth from 2024 to 2031. It presents key statistics, trends, and market
GMP Protein (E. coli) Contract Manufacturing Market Insights and Growth Drivers Shaping the Market in 2024 To 2031 | Merck & Co., Inc., Thermo Fisher Scientific Inc.
GMP Protein (E. coli) Contract Manufacturing Market Insights and Growth Drivers …
Global GMP protein (E. coli) contract manufacturing market is estimated to be valued at US$ 685.8 million in 2022 and is expected to exhibit a CAGR of 9.7% during the forecast period (2022-2030) The research report on the GMP Protein (E. coli) Contract Manufacturing Market provides an in-depth analysis of the industry's current state and projected growth from 2024 to 2031. It presents key statistics, trends, and market dynamics that not
Plexiform Neurofibromas Treatment Market Future Growth, Size, Share, Trends, Demand, Segmentation and Forecasts to 2024-2031 | AstraZeneca, Pfizer Inc., Sun Pharmaceuticals Industries Limited
Plexiform Neurofibromas Treatment Market Future Growth, Size, Share, Trends, Dem …
The global plexiform neurofibromas treatment market is estimated to be valued at US$ 1,371.14 million in 2022 and is expected to exhibit a CAGR of 8.2% during the forecast period (2022-2030). The research report on the Plexiform Neurofibromas Treatment Market provides an in-depth analysis of the industry's current state and projected growth from 2024 to 2031. It presents key statistics, trends, and market dynamics that not only clarify the existing landscape

All 5 Releases


More Releases for Asia

South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,
RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019". The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients. Asked to comment on the move, Luke Palmer, the